Lubiprostone for Functional Constipation in the Under 18 Years Patients
Status:
Not yet recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
We will enroll subjects 8 - < 18 years of age, fulfilling Rome IV criteria for functional
constipation. They will be randomly assigned to either Lubiprostone treatment (study group),
or the control group (will receive either lactulose or Bisacodyl tablets). safety and
efficacy will be assessed.